Table 1 Laboratory test for pituitary macroadenoma

Hemoglobin (g/dL)

14.6

13–18

Platelet (10³/μL)

165

140–450

WBC (10³/μL)

5.5

4.0–10.0

Glucose (mg/dL)

97

70–99

Total bilirubin (mg/dL)

0.4

0.3–1.2

Aspartate aminotransferase (IU/L)

36

15–41

Blood urea nitrogen (mg/dL)

19.4

8–20

Creatinine (mg/dL)

1.1

0.4–1.2

Sodium (mEq/L)

141.7

136–144

Potassium (mEq/L)

4.0

3.5–5.1

Cortisol (μg/dL)

11.86

9.52–26.21

ACTH (pg/mL)

31.26

10.00–70.00

FREE-T4 (ng/dL)

1.18

0.89–1.79

TSH (μIU/mL)

1.98

0.25–4.00

Prolactin (ng/mL)

7.69

1–18

LH (mIU/mL)

2.74

1.8–8.4

FSH (mIU/mL)

2.10

2.2–10

Testosterone (ng/mL)

1.90

2.51–10.63

GH (ng/mL)

2.29

< 5.0

IGF-I (ng/mL)

408.52

94–262

OGTT test

GH nadir (ng/mL)

0.45

< 1

1 mg overnight dexamethasone suppression test

Cortisol (μg/dL)

1.18

< 1.8

Follow-up

IGF-I (ng/mL) (November 2021)

359.52

94–262

IGF-I (ng/mL) (March 2022)

342.48

94–262

IGF-I (ng/mL) (September 2022)

411.76

94–262

OGTT test (October 2022)

GH nadir (ng/mL)

1.44

< 1

Cortisol (μg/dL)

6.76

9.52–26.21

 ACTH (pg/mL)

6.98

10.00–70.00

Postoperation

IGF-I (ng/mL) (November 2022)

171.53

94–262